Skip to main content
Log in

Implantation of Culture-Expanded Bone Marrow Derived Mesenchymal Stromal Cells for Treatment of Osteonecrosis of the Femoral Head

  • Original Article
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

Background:

Although core decompression (CD) with stem cell for the treatment of osteonecrosis of the femoral head (ONFH) showed promising results in many reports, the efficacy remains uncertain. We aimed to evaluate the efficacy of CD with culture-expanded autologous bone marrow-derived mesenchymal stem cell (BM-MSC) implantation in early stage ONFH.

Methods:

A total of 18 patients (22 hips) with ONFH who underwent CD with culture-expanded BM-MSC implantation from September 2013 to July 2020 were retrospectively reviewed. The median age was 35.0 years [interquartile range (IQR), 28.5–42.0], and the median follow-up period was 4.0 years (IQR, 2.0–5.3). The median number of MSCs was 1.06 × 108. To evaluate radiographic and clinical outcomes, Association Research Circulation Osseous (ARCO) classifications, Japanese Investigation Committee classification, combined necrotic angle (CNA) visual analogue scale (VAS) and Harris Hip Score (HHS) were checked at each follow-up.

Results:

The preoperative stage of ONFH was ARCO 2 in 14 hips and ARCO 3a in 8 hips. The ARCO staging was maintained in 7 hips in ARCO 2 and 4 hips in ARCO 3a. The radiographic failure rate of ARCO 2 and 3a was 14.3 and 50%, respectively. Furthermore, CNA decreased to more than 20° in 6 hips (four were ARCO 2 and two were ARCO 3a).There was no significant difference in the VAS and HHS (P = 0.052 and P = 0.535, respectively). Total hip arthroplasty was performed in 4 hips.

Conclusion:

CD with culture-expanded autologous BM-MSCs showed promising results for the treatment of early stage ONFH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability statement

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Shimizu K, Moriya H, Akita T, Sakamoto M, Suguro T. Prediction of collapse with magnetic resonance imaging of avascular necrosis of the femoral head. J Bone Joint Surg Am. 1994;76:215–23.

    Article  CAS  PubMed  Google Scholar 

  2. Hines JT, Jo WL, Cui Q, Mont MA, Koo KH, Cheng EY, et al. Osteonecrosis of the femoral head: an updated review of ARCO on pathogenesis, staging and treatment. J Korean Med Sci. 2021;36: e177.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bayliss LE, Culliford D, Monk AP, Glyn-Jones S, Prieto-Alhambra D, Judge A, et al. The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Lancet. 2017;389:1424–30.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Park JW, Lee YK, Kim HS, Kim JT, Ha YC, Koo KH. Perioperative concerns and complaints of patients undergoing total hip arthroplasty. Clin Orthop Surg. 2023;15:37–41.

    Article  PubMed  Google Scholar 

  5. Atilla B, Bakircioglu S, Shope AJ, Parvizi J. Joint-preserving procedures for osteonecrosis of the femoral head. EFORT Open Rev. 2019;4:647–58.

    Article  PubMed  Google Scholar 

  6. Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50:325–30.

    Article  PubMed  Google Scholar 

  7. Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty. 2012;27:679–86.

    Article  PubMed  Google Scholar 

  8. Mont MA, Ragland PS, Etienne G. Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling. Clin Orthop Relat Res. 2004;429:131–8.

    Article  Google Scholar 

  9. Chen CC, Lin CL, Chen WC, Shih HN, Ueng SW, Lee MS. Vascularized iliac bone-grafting for osteonecrosis with segmental collapse of the femoral head. J Bone Joint Surg Am. 2009;91:2390–4.

    Article  PubMed  Google Scholar 

  10. Houdek MT, Bayne CO, Bishop AT, Shin AY. The outcome and complications of vascularised fibular grafts. Bone Joint J. 2017;99-B:134–38.

  11. Yoo MC, Kim KI, Hahn CS, Parvizi J. Long-term followup of vascularized fibular grafting for femoral head necrosis. Clin Orthop Relat Res. 2008;466:1133–40.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sugioka Y, Hotokebuchi T, Tsutsui H. Transtrochanteric anterior rotational osteotomy for idiopathic and steroid-induced necrosis of the femoral head. Indications and long-term results. Clin Orthop Relat Res. 1992;277:111–20.

  13. Xu Y, Jiang Y, Xia C, Wang Y, Zhao Z, Li T. Stem cell therapy for osteonecrosis of femoral head: opportunities and challenges. Regen Ther. 2020;15:295–304.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mao L, Jiang P, Lei X, Ni C, Zhang Y, Zhang B, et al. Efficacy and safety of stem cell therapy for the early-stage osteonecrosis of femoral head: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2020;11:445.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br. 1999;81:349–55.

    Article  CAS  PubMed  Google Scholar 

  16. Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;49:1005–9.

    Article  PubMed  Google Scholar 

  17. Hernigou P, Beaujean F. Bone marrow activity in the upper femoral extremity in avascular osteonecrosis. Rev Rhum Engl Ed. 1993;60:610.

    Google Scholar 

  18. Piuzzi NS, Chahla J, Schrock JB, LaPrade RF, Pascual-Garrido C, Mont MA, et al. Evidence for the use of cell-based therapy for the treatment of osteonecrosis of the femoral head: a systematic review of the literature. J Arthroplasty. 2017;32:1698–708.

    Article  PubMed  Google Scholar 

  19. Andriolo L, Merli G, Tobar C, Altamura SA, Kon E, Filardo G. Regenerative therapies increase survivorship of avascular necrosis of the femoral head: a systematic review and meta-analysis. Int Orthop. 2018;42:1689–704.

    Article  PubMed  Google Scholar 

  20. Lim YW, Kim YS, Lee JW, Kwon SY. Stem cell implantation for osteonecrosis of the femoral head. Exp Mol Med. 2013;45: e61.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Pepke W, Kasten P, Beckmann NA, Janicki P, Egermann M. Core decompression and autologous bone marrow concentrate for treatment of femoral head osteonecrosis: a randomized prospective study. Orthop Rev (Pavia). 2016;8:6162.

    PubMed  Google Scholar 

  22. Nally FJ, Zanotti G, Buttaro MA, Diaz Dilernia F, Mansilla IG, Comba FM, et al. THA conversion rate comparing decompression alone, with autologous bone graft or stem cells in osteonecrosis. Hip Int. 2018;28:189–93.

    Article  PubMed  Google Scholar 

  23. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393–403.

    CAS  PubMed  Google Scholar 

  24. Kim BC, Yoon JH, Choi B, Lee J. Mandibular reconstruction with autologous human bone marrow stem cells and autogenous bone graft in a patient with plexiform ameloblastoma. J Craniofac Surg. 2013;24:e409–11.

    Article  PubMed  Google Scholar 

  25. Yoon BH, Mont MA, Koo KH, Chen CH, Cheng EY, Cui Q, et al. The 2019 revised version of association research circulation osseous staging system of osteonecrosis of the femoral head. J Arthroplasty. 2020;35:933–40.

    Article  PubMed  Google Scholar 

  26. Sugano N, Atsumi T, Ohzono K, Kubo T, Hotokebuchi T, Takaoka K. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci. 2002;7:601–5.

    Article  PubMed  Google Scholar 

  27. Ha YC, Jung WH, Kim JR, Seong NH, Kim SY, Koo KH. Prediction of collapse in femoral head osteonecrosis: a modified kerboul method with use of magnetic resonance images. J Bone Joint Surg Am. 2006;88:35–40.

    PubMed  Google Scholar 

  28. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. an end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51:737–55.

  29. Roth A, Beckmann J, Bohndorf K, Fischer A, Heiss C, Kenn W, et al. S3-guideline non-traumatic adult femoral head necrosis. Arch Orthop Trauma Surg. 2016;136:165–74.

    Article  CAS  PubMed  Google Scholar 

  30. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;405:14–23.

    Article  Google Scholar 

  31. Wang Y, Ma X, Chai W, Tian J. Multiscale stem cell technologies for osteonecrosis of the femoral head. Stem Cells Int. 2019;2019:8914569.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Li R, Lin QX, Liang XZ, Liu GB, Tang H, Wang Y, et al. Stem cell therapy for treating osteonecrosis of the femoral head: From clinical applications to related basic research. Stem Cell Res Ther. 2018;9:291.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Hernigou P, Dubory A, Homma Y, Guissou I, Flouzat Lachaniette CH, Chevallier N, et al. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop. 2018;42:1639–49.

    Article  PubMed  Google Scholar 

  34. Hernigou P, Trousselier M, Roubineau F, Bouthors C, Chevallier N, Rouard H, et al. Stem cell therapy for the treatment of hip osteonecrosis: a 30-year review of progress. Clin Orthop Surg. 2016;8:1–8.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hauzeur JP, De Maertelaer V, Baudoux E, Malaise M, Beguin Y, Gangji V. Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. Int Orthop. 2018;42:1429–35.

    Article  PubMed  Google Scholar 

  36. Persiani P, De Cristo C, Graci J, Noia G, Gurzi M, Villani C. Stage-related results in treatment of hip osteonecrosis with core-decompression and autologous mesenchymal stem cells. Acta Orthop Belg. 2015;81:406–12.

    PubMed  Google Scholar 

  37. Kawate K, Yajima H, Ohgushi H, Kotobuki N, Sugimoto K, Ohmura T, et al. Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs. 2006;30:960–2.

    Article  CAS  PubMed  Google Scholar 

  38. Aoyama T, Goto K, Kakinoki R, Ikeguchi R, Ueda M, Kasai Y, et al. An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts. Tissue Eng Part B Rev. 2014;20:233–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Palekar G, Bhalodiya HP, Archik S, Trivedi K. Retrospective study on implantation of autologous-cultured osteoblasts for the treatment of patients with avascular necrosis of the femoral head. Orthop Res Rev. 2021;13:15–23.

    PubMed  PubMed Central  Google Scholar 

  40. Gomez-Barrena E, Padilla-Eguiluz NG, Rosset P, Hernigou P, Baldini N, Ciapetti G, et al. Osteonecrosis of the femoral head safely healed with autologous, expanded, bone marrow-derived mesenchymal stromal cells in a multicentric trial with minimum 5 years follow-up. J Clin Med. 2021;10.

  41. Sadat-Ali M, Azam MQ, Elshabouri EM, Tantawy AM, Acharya S. Stem cell therapy for avascular necrosis of femoral head in sickle cell disease: report of 11 cases and review of literature. Int J Stem Cells. 2017;10:179–83.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Mardones R, Camacho D, Monsalvo F, Zulch N, Jofre C, Minguell JJ. Treatment of osteonecrosis of the femoral head by core decompression and implantation of fully functional ex vivo-expanded bone marrow-derived mesenchymal stem cells: a proof-of-concept study. Stem Cells Cloning. 2019;12:11–6.

    PubMed  PubMed Central  Google Scholar 

  43. Nishii T, Sugano N, Ohzono K, Sakai T, Haraguchi K, Yoshikawa H. Progression and cessation of collapse in osteonecrosis of the femoral head. Clin Orthop Relat Res. 2002;400:149–57.

    Article  Google Scholar 

  44. Takashima K, Sakai T, Hamada H, Takao M, Sugano N. Which classification system is most useful for classifying osteonecrosis of the femoral head? Clin Orthop Relat Res. 2018;476:1240–9.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Kuroda Y, Tanaka T, Miyagawa T, Kawai T, Goto K, Tanaka S, et al. Classification of osteonecrosis of the femoral head: who should have surgery? Bone Joint Res. 2019;8:451–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Hauzeur JP, Lechanteur C, Baudoux E, De Maertelaer V, Pather S, Katz R, et al. Did osteoblastic cell therapy improve the prognosis of pre-fracture osteonecrosis of the femoral head? a randomized, controlled trial. Clin Orthop Relat Res. 2020;478:1307–15.

    Article  PubMed  Google Scholar 

  47. Wyles CC, Houdek MT, Crespo-Diaz RJ, Norambuena GA, Stalboerger PG, Terzic A, et al. Adipose-derived mesenchymal stem cells are phenotypically superior for regeneration in the setting of osteonecrosis of the femoral head. Clin Orthop Relat Res. 2015;473:3080–90.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Yoon PW, Kang JY, Kim CH, Lee SJ, Yoo JJ, Kim HJ, et al. Culture-expanded autologous adipose-derived mesenchymal stem cell treatment for osteonecrosis of the femoral head. Clin Orthop Surg. 2021;13:37–46.

    Article  PubMed  Google Scholar 

  49. Chen C, Qu Z, Yin X, Shang C, Ao Q, Gu Y, et al. Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: a three-year follow-up study. Mol Med Rep. 2016;14:4209–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Martin JR, Houdek MT, Sierra RJ. Use of concentrated bone marrow aspirate and platelet rich plasma during minimally invasive decompression of the femoral head in the treatment of osteonecrosis. Croat Med J. 2013;54:219–24.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Rastogi S, Sankineani SR, Nag HL, Mohanty S, Shivanand G, Marimuthu K, et al. Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study. Musculoskelet Surg. 2013;97:223–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported by the Korean Fund for Regenerative Medicine (KFRM) grant funded by the Korea Government (the Ministry of Science and ICT, the Ministry of Health & Welfare), No. 22D0801L1 and No. 22C0604L1.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: SHB, SYK. Data curation: S-DY, BJS. Formal analysis: BJS. Investigation: SDY, BJS. Methodology: SYK. Supervision: SYK. Validation: SHB, SYK. Visualization: BJS. Writing—original draft: SDY, BJS. Writing—review and editing: SDY, BJS.

Corresponding author

Correspondence to Shin-Yoon Kim.

Ethics declarations

Conflict of interest

Each author certifies that he has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.

Ethical statement

The study protocol was approved by the institutional review board of our hospital (IRB No. KNUH-2022-06-010-001). Informed consent was confirmed by the IRB.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yoon, SD., Shim, BJ., Baek, SH. et al. Implantation of Culture-Expanded Bone Marrow Derived Mesenchymal Stromal Cells for Treatment of Osteonecrosis of the Femoral Head. Tissue Eng Regen Med (2024). https://doi.org/10.1007/s13770-024-00647-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13770-024-00647-z

Keywords

Navigation